{"id":"W2031964028","doi":"10.1097/jto.0b013e3181ba2f1d","title":"Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Carboplatin; Pharmacodynamics; Pharmacokinetics; Paclitaxel; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacology; Lung cancer; Oncology; Adverse effect; Area under the curve; Dosing; Gastroenterology; Cancer; Chemotherapy; Progressive disease; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008306907,0.0004865927,0.001044271,0.0003901962,0.0002603388,0.0008972876,0.0004586175,0.0005557347,0.0006815198],"category_scores_gemma":[0.002160016,0.0004048908,0.0006706864,0.0004226704,0.0005016743,0.0006464284,0.0001326689,0.002109961,0.0003260694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00117663,"about_ca_system_score_gemma":0.0007833738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001697272,"about_ca_topic_score_gemma":0.0023422,"domain_scores_codex":[0.9993644,0.0002864823,0.00003379366,0.00009190416,0.0001281426,0.00009519581],"domain_scores_gemma":[0.9993175,0.0001918396,0.000223291,0.00006445005,0.0000424955,0.0001604456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.444363,0.01253785,0.05594299,0.0003020002,0.002432536,0.001093945,0.0003611275,0.007515847,0.2018118,0.0004713438,0.003262905,0.2699047],"study_design_scores_gemma":[0.0412595,0.3561209,0.4082674,0.0001052164,0.006185945,0.006414645,0.0003564149,0.03142111,0.1374662,0.0006493637,0.01156435,0.0001890313],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970301,0.001528383,0.0003045365,0.0001436922,0.00004303691,0.00003221534,0.0001387695,0.0000404161,0.0007387788],"genre_scores_gemma":[0.9989793,0.0003255626,0.0001264742,0.00006408153,0.00003498986,0.0000159862,0.0001407559,0.00001097959,0.0003019338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001697272,"threshold_uncertainty_score":0.008537054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01482119092139858,"score_gpt":0.3341232052619967,"score_spread":0.3193020143405981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}